Title: Opioid PACE Act of 2017
Policy area: Health

Summary:
Opioid Preventing Abuse through Continuing Education Act of 2017 or the Opioid PACE Act of 2017
This bill amends the Controlled Substances Act to require a practitioner (other than a hospital, pharmacy, pharmacist, or veterinarian) to comply with a training requirement, as a condition of obtaining or renewing a registration to prescribe or dispense opioids for the treatment of pain or pain management.

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2063 Introduced in House (IH)]

<DOC>






115th CONGRESS
  1st Session
                                H. R. 2063

To amend the Controlled Substances Act to require certain training as a 
  condition of registration to prescribe or dispense opioids for the 
     treatment of pain or pain management, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 6, 2017

Mr. Schneider introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend the Controlled Substances Act to require certain training as a 
  condition of registration to prescribe or dispense opioids for the 
     treatment of pain or pain management, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Opioid Preventing Abuse through 
Continuing Education Act of 2017'' or the ``Opioid PACE Act of 2017''.

SEC. 2. PRACTITIONER EDUCATION.

    (a) Training Requirements.--
            (1) In general.--Section 303(f) of the Controlled 
        Substances Act (21 U.S.C. 823(f)) is amended--
                    (A) by redesignating paragraphs (1) through (5) as 
                subparagraphs (A) through (E), respectively;
                    (B) by striking ``(f) The Attorney General'' and 
                inserting ``(f)(1) Subject to paragraph (2), the 
                Attorney General''; and
                    (C) by adding at the end the following:
    ``(2)(A) To be registered under paragraph (1) to prescribe or 
otherwise dispense opioids for the treatment of pain, or pain 
management, a practitioner (other than a hospital, a pharmacy, a 
pharmacist, or a veterinarian) shall comply with the 12-hour training 
requirement of this paragraph at least once during each 3-year period.
    ``(B) The training requirement of this paragraph is that the 
practitioner has completed not less than 12 hours of training (through 
classroom situations, seminars at professional society meetings, 
electronic communications, or otherwise) with respect to--
            ``(i) pain management treatment guidelines and best 
        practices,
            ``(ii) early detection of opioid addiction, and
            ``(iii) the treatment and management of opioid-dependent 
        patients,
that is provided by the American Society of Addiction Medicine, the 
American Academy of Addiction Psychiatry, the American Medical 
Association, the American Osteopathic Association, the American 
Psychiatric Association, the American Academy of Pain Management, the 
American Pain Society, the American Academy of Pain Medicine, the 
American Board of Pain Medicine, the American Society of Interventional 
Pain Physicians, or any other organization that the Secretary 
determines is appropriate for purposes of this paragraph.''.
            (2) Funding.--The Drug Enforcement Administration shall 
        fund the enforcement of the requirements specified in section 
        303(f)(2) of the Controlled Substances Act (as added by 
        paragraph (1)) through the use of a portion of the licensing 
        fees paid by controlled substance prescribers under the 
        Controlled Substances Act (21 U.S.C. 801 et seq.).
    (b) Establishment of Training Modules.--
            (1) In general.--The Secretary of Health and Human Services 
        shall establish or support the establishment of one or more 
        training modules to be used to meet the training requirement 
        under section 303(f)(2) of the Controlled Substances Act (as 
        added by subsection (a)(1)).
            (2) Eligible entities.--To be eligible to receive support 
        under paragraph (1), an entity shall be--
                    (A) one of the organizations listed in subparagraph 
                (B) of section 303(f)(2) of the Controlled Substances 
                Act (as added by subsection (a)(1)); or
                    (B) any other organization that the Secretary 
                determines is appropriate to provide training under 
                such section 303(f)(2).
            (3) Authorization of appropriations.--To carry out this 
        subsection, there is authorized to be appropriated $1,000,000 
        for each of fiscal years 2018 through 2022.
                                 <all>